Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$63K Sell
1,096
-2,659
-71% -$159K 0.29% 194
2020
Q2
$246K Buy
+3,755
New +$232K 0.17% 47
2019
Q4
$572K Buy
7,924
+894
+13% +$60.9K 0.3% 28
2019
Q3
$465K Buy
7,030
+1,408
+25% +$90.5K 0.3% 17
2019
Q2
$349K Sell
5,622
-435
-7% -$25.1K 0.28% 152
2019
Q1
$328K Buy
6,057
+1,762
+41% +$99K 0.29% 175
2018
Q4
$252K Buy
4,295
+1,417
+49% +$88.8K 0.17% 186
2018
Q3
$190K Buy
2,878
+236
+9% +$15.6K 0.3% 47
2018
Q2
$175K Buy
2,642
+521
+25% +$35.1K 0.29% 152
2018
Q1
$142K Sell
2,121
-1,634
-44% -$110K 0.18% 312
2017
Q4
$246K Buy
+3,755
New +$244K 0.17% 47

Other funds holding DOX

Cerebellum's DOX Position: Q3 2020 in Review

Cerebellum reduced its Amdocs (DOX) stake by 71% in Q3 2020, selling an estimated $159K and leaving 1,096 shares worth $63K. The position accounts for 0.29% of the portfolio, ranked #194.

Cerebellum first reported a position in DOX in Q4 2017 and has held it in 11 quarters since. The position peaked at $572K in Q4 2019. 396 funds tracked by Wall St. Rank hold DOX as of Q3 2020.

  • Cerebellum held 1,096 shares of Amdocs worth $63K as of Q3 2020.
  • Cerebellum sold 2,659 Amdocs shares in Q3 2020, an estimated $159K.
  • Amdocs made up 0.29% of Cerebellum's portfolio in Q3 2020, its #194 holding.
  • Cerebellum first reported a position in Amdocs in Q4 2017 and has held it in 11 quarters since.
  • Cerebellum's Amdocs position peaked at $572K in Q4 2019.
  • 396 funds tracked by Wall St. Rank held Amdocs as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.